Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/1/2020
SIETES contiene 92882 citas

 
 
<< anterior 21 a 40 de 51 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJM, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestagen type: results of the MEGA case-control study. BMJ 2009;339:561-2. [Ref.ID 86731]
22.Tiene citas relacionadas Cita con resumen
Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:557-60. [Ref.ID 86730]
23.Tiene citas relacionadas Cita con resumen
Dunn N. Oral contraceptives and venous thromboembolism. BMJ 2009;339:521-2. [Ref.ID 86720]
24.
28. Cita con resumen
Roy S N, Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Saf 2004;27:75-90. [Ref.ID 68995]
30. Cita con resumen
Anónimo. Danish HRT study stopped. Scrip 2003;2907:20. [Ref.ID 68393]
31.
Anónimo. Estradiol + progestatif. Encore des estroprogestatifs pour la ménopause. Prescrire 2003;23:575. [Ref.ID 67269]
32.Tiene citas relacionadas Cita con resumen
Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27. [Ref.ID 67071]
33.Tiene citas relacionadas Cita con resumen
Beral V, Banks E, Reeves G. Long-term effects of hormone replacement therapy. Authors' reply. Lancet 2003;361:254-5. [Ref.ID 64807]
35.
Fender GRK, Prentice A, Nixon R M, Gorst T, Duffy SW, Day NE, Smith SK. Management of menorrhagia: an audit of practices in the Anglia menorrhagia education study. BMJ 2001;322:523-4. [Ref.ID 55394]
36.
Zdravkovic M, Müller M, Larsen S, Degenkolb J, Pabst G. Bioequivalence and relative bioavailability of three estradiol and norethisterone acetate-containing hormone replacement therapy tablets. Int J Clin Pharmacol Ther 2001;39:41-6. [Ref.ID 54798]
37. Cita con resumen
Gilbert D, Walley T, New B. Lifestyle medicines. BMJ 2000;321:1341-4. [Ref.ID 53985]
39.
Godsland IF, Winkler U, Lidegaard O, Crook D. Occlusive vascular diseases in oral contraceptive users: epidemiology, pathology and mechanisms. Drugs 2000;60:721-869. [Ref.ID 53285]
Seleccionar todas
 
<< anterior 21 a 40 de 51 siguiente >>